Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Coherus Bio (CHRS)

Coherus Bio (CHRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coherus Bio 333 TWIN DOLPHIN DRIVE SUITE 600 REDWOOD CITY CA 94065 USA

P: 650-649-3530 F: 215-638-6914

Description:

Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients. Coherus Biosciences, Inc. is headquartered in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 1,331,048
Shares Outstanding, K 70,129
Annual Sales, $ 0 K
Annual Net Income, $ -209,340 K
Last Quarter Sales, $ 111,680 K
Last Quarter Net Income, $ 47,040 K
60-Month Beta 2.90
% of Insider Shareholders 18.20%
% of Institutional Shareholders 98.31%
Float, K 57,366
% Float 81.80%

Growth:

1-Year Return 56.29%
3-Year Return -32.81%
5-Year Return 45.44%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -15.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/06/19
Earnings Per Share ttm -0.26
EPS Growth vs. Prev Qtr 96.88%
EPS Growth vs. Prev Year 172.41%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

CHRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -5.37
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 0.00
Return-on-Assets (Before Tax) -5.62
Profit Margin % N/A
Net Margin % -1.54
Debt/Equity N/A
Price/Sales 6.02
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.80
Interest Coverage -20.63
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar